Prenatal testing


Also found in: Dictionary, Thesaurus, Wikipedia.

Prenatal testing

Testing for a disease such as a genetic condition in an unborn baby.
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
The United States Non-Invasive Prenatal Testing market will register a robust CAGR of more than 13% by 2026.
We have recently found ourselves center stage in the furor surrounding prenatal testing for Down syndrome, are has faced fierce criticism in the media and regular attacks on Twitter and Facebook.
Incidental detection of maternal neoplasia in noninvasive prenatal testing. Clin Chem 2018;64:329-35.
The company will offer non-invasive prenatal testing, and provide LifeCodexx access to the complete competencies of the Eurofins Group and its global distribution network.
Non-invasive prenatal testing (NIPT) test can detect birth defects such as neural tube defects, Down syndrome, chromosome abnormalities, genetic disorders and other conditions, such as spina bifida, cleft palate, Tay-Sachs disease, sickle cell anemia, thalassemia, cystic fibrosis, Muscular dystrophy, and fragile X syndrome.
M2 PHARMA-April 11, 2017-Illumina Launches the VeriSeq NIPT Noninvasive Prenatal Testing Solution in Europe
* PHYSICIANS' DEFENSE: Further prenatal testing for amniotic fluid levels was unwarranted.
Heidi Lindh, MS, CGC, Executive Director of Genetic Support Foundation, adds, "In addition to launching our website, we are thrilled to announce the availability of our educational video that we developed to help patients make informed decisions about noninvasive prenatal testing. This video comes at a time when there is a real need for objective information, and we are hopeful that this video will be a useful tool for providers and patients."
Pregnant women who used an interactive computer program to help them decide whether to undergo prenatal testing were 55% less likely to choose invasive testing than women who received standard prenatal care, even when they were offered free testing, researchers reported.
The need for Chloe's law is two-fold: [1] the Kennedy-Brownback Act has never been funded or implemented, which is why states have taken on state-level measures; and [2] while professional guidelines recommend offering prenatal testing for Down syndrome to all patients, those same guidelines recommend that patients receive up-to-date, accurate information about Down syndrome and referral to parent support organizations, but that is not happening with the same regularity as the offering of prenatal testing.
Our records did not allow us to analyse how many patients only came to SA for prenatal testing, but are resident elsewhere in Africa and how many are resident locally, but, anecdotally, both scenarios do occur.